Increased Levels of Tumor-Infiltrating Lymphocytes are Associated with Improved Recurrence-Free Survival in Stage 1A Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Increased Levels of Tumor-Infiltrating Lymphocytes are Associated with Improved Recurrence-Free Survival in Stage 1A Non-Small-Cell Lung Cancer

Published:2011-11 Issue:1 Volume:171 Page:1-5
ISSN:0022-4804
Container-title:Journal of Surgical Research
language:en
Short-container-title:Journal of Surgical Research

Author:

Horne Zachary D.,Jack Robert,Gray Zachary T.,Siegfried Jill M.,Wilson David O.,Yousem Samuel A.,Nason Katie S.,Landreneau Rodney J.,Luketich James D.,Schuchert Matthew J.

Publisher

Elsevier BV

Subject

Surgery

Reference24 articles.

1. Anatomic segmentectomy in the treatment of stage I non-small-cell lung cancer;Schuchert;Ann Thorac Surg,2007

2. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma: Five-year survival and patterns of intrathoracic recurrence;Warren;J Thorac Cardiovasc Surg,1994

3. Survival after pathological stage IA non-small-cell lung cancer: Tumor size matters;Birim;Ann Thorac Surg,2005

4. A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma;Eerola;Clin Cancer Res,2000

5. Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma;Kondratiev;Clin Cancer Res,2004

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting histopathological features of aggressiveness in lung cancer using CT radiomics: a systematic review;Clinical Radiology;2024-09

2. Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS study;Future Oncology;2024-08-12

3. Oral administration of oligo fucoidan improves the survival rate, quality of life, and immunity in patients with lung cancer;Food & Nutrition Research;2024-07-03

4. Recent advances in lung cancer research: unravelling the future of treatment;Updates in Surgery;2024-04-06

5. NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy;Frontiers in Immunology;2024-02-07